2017-03-20,Finding Bullish and Bearish Market Reversals
2017-03-12,Biotechs Among 5 Stocks Setting Up for Major Breakouts
2017-03-10,Biotech Stock Mailbag: Puma's Rebound Explained, TG Therapeutics Approval Debate, Aurinia Next Steps
2017-03-09,These Stocks Are Trending Up With Monster Volume
2017-03-09,7 Stocks Trending Up With Monster Volume
2017-03-02,Puma Biotechnology To Present At Cowen's Health Care Conference
2017-03-02,Dow Declines, Caterpillar Weighs on Index as Feds Swarm Offices
2017-03-02,Stocks Slide as Rally Runs Out of Steam; Snap Makes Trading Debut
2017-03-02,Biotech Premarket Movers: Aurinia, Puma, PTC, Juno
2017-03-02,What You Need to Know About Roche AG's Breast Cancer Drug Perjeta
2017-03-02,Roche Shares Soar, Puma Bio Sinks on Perjeta Breast Cancer Study Win
2017-03-01,Puma Biotechnology Announces Publication Of Abstracts On Neratinib For The AACR Annual Meeting 2017
2017-03-01,Puma Biotechnology Provides Update On Review Of Marketing Authorisation Application For PB272
2017-03-01,Puma Biotechnology Reports Fourth Quarter And Full Year 2016 Financial Results
2017-02-14,Puma Biotechnology To Present At RBC Capital Markets Healthcare Conference
2017-02-08,Puma Biotechnology To Present At LEERINK Partners Global Healthcare Conference
2017-02-03,Biotech Stock Mailbag: Do Investors Have an 'Aphinity' for Shorting Puma Into Trial Results?
2017-01-09,Newman Ferrara LLP Announces Corporate Governance Investigation Of Puma Biotechnology, Inc. - PBYI
2017-01-06,Puma Biotechnology Expands Cohort In Phase II SUMMIT Trial Of PB272 In HER2 Mutation-Positive Cancer Patients
2017-01-03,Puma Biotechnology To Present At J.P. Morgan Healthcare Conference
2017-01-03,17 Thoughts on Biotech Stocks to Kick Off 2017
2016-12-22,What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016
2016-12-20,First Week of PBYI February 2017 Options Trading
2016-12-19,Puma Biotechnology To Move Stock Exchange Listing To Nasdaq
2016-12-08,Figure 1: Treatment Emergent Diarrhea By Month In ExteNET Versus CONTROL (Graphic: Business Wire)
2016-12-07,Puma Biotechnology Presents Results Of Biomarker Analysis Of Phase II Trial Of PB272 In Neoadjuvant Treatment Of HER2-Positive Locally Advanced Breast Cancer At The 2016 San Antonio Breast Cancer Symposium
2016-12-07,Puma Biotechnology Presents Interim Results Of Phase II Trial Of PB272 For ERBB2 (HER2) Mutant, HER2 Non-Amplified, Metastatic Breast Cancer At The 2016 San Antonio Breast Cancer Symposium
2016-12-07,Cascadian Therapeutics Enlarges Breast Cancer Pill Study to Meet FDA Registration Standards
2016-12-06,Puma Biotechnology Initiates A Managed Access Program For PB272 (Neratinib) Outside The United States
2016-11-15,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Puma Biotechnology, Inc. (PBYI)
2016-11-15,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Puma Biotechnology, Inc. - PBYI
2016-11-14,Puma Biotechnology Announces Presentations Of Investigational Data At The San Antonio Breast Cancer Symposium (SABCS)
2016-11-14,Puma Bio Falls on Escalating Concerns About Diarrhea Risk With Breast Cancer Drug
2016-11-11,Puma Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Puma Biotechnology, Inc. - PBYI
2016-11-09,Puma Biotechnology Reports Third Quarter 2016 Financial Results
2016-10-31,Puma Biotechnology To Present At Credit Suisse Healthcare Conference
2016-10-31,Lifshitz & Miller Law Firm Announces Investigation Of Electronics For Imaging, Inc., Ferrellgas Partners LP, Fusion Pharm, Inc., Humana Inc., KemPharm, Inc., National Beverage Corp., Puma Biotechnology, Inc., And TG Therapeutics, Inc.
2016-10-28,PUMA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Puma Biotechnology, Inc. - PBYI
2016-10-25,Puma Biotechnology Closes $172 Million Public Offering Of Common Stock
2016-10-24,June 2017 Options Now Available For Puma Biotechnology (PBYI)
2016-10-21,Puma Biotechnology Announces Underwriters' Full Exercise Of Option To Purchase Additional Shares
2016-10-20,Puma Bio's Desperate Money Grab Signals Breast Cancer Drug Trouble
2016-10-19,Puma Biotechnology Prices Public Offering Of Common Stock
2016-10-18,Puma Biotechnology (PBYI) Stock Down in After-Hours Trading on Public Offering
2016-10-18,Puma Biotechnology Announces Proposed Public Offering Of Common Stock
2016-10-14,PUMA INVESTIGATION INITIATED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Puma Biotechnology, Inc. - PBYI
2016-10-12,Robbins Arroyo LLP: Puma Biotechnology, Inc. (PBYI) Investors Survive Defendants' Motion To Dismiss In Securities Class Action
2016-10-11,Puma Biotechnology, Inc. Shareholder Alert: Schubert Firm Investigates Company's Top Executives
2016-10-10,Johnson & Weaver, LLP Initiates Investigations Of Puma Biotechnology, Inc., Virtus Investment Partners, Inc., AAC Holdings, Inc. And Spectrum Pharmaceuticals, Inc.; Encourages Long-Term Investors To Contact The Firm Regarding Their Legal Rights
2016-09-30,Biotech Stock Mailbag: Dynavax, Puma, Ariad
2016-09-22,Puma Biotechnology Shares Leap Forward
2016-09-20,Why Puma Biotechnology (PBYI) Stock Is Surging Today
2016-09-20,Puma Biotechnology Announces U.S. FDA Acceptance Of New Drug Application For PB272 (Neratinib) For Extended Adjuvant Treatment Of HER2-Positive Early Stage Breast Cancer
2016-09-02,Jim Cramer's Top Takeaways: Salesforce.com, GCP Applied Technologies, Puma Biotechnology
2016-09-01,Jim Cramer's 'Mad Money' Recap: What Is Going on With This Market?
2016-08-24,Noteworthy Wednesday Option Activity: PBYI, MOV, BOFI
2016-08-23,4 Biotech Stock Charts You Must See
2016-08-22,Puma Biotechnology Announces European Medicines Agency Validation Of Marketing Authorization Application For PB272 (Neratinib) As Extended Adjuvant Treatment Of HER2-Positive Early Stage Breast Cancer In Europe
2016-08-09,Puma Biotechnology Reports Second Quarter 2016 Financial Results
2016-07-29,Biotech Stock Mailbag: Puma Roars, Relypsa Soars, XBiotech Bombs
2016-07-22,Morning Movers: GE, AMD, P, PBYI
2016-07-21,Puma Biotechnology Announces Interim 5-Year Disease Free Survival Data From Phase III Trial Of PB272 (Neratinib) In Extended Adjuvant HER2-Positive Early Stage Breast Cancer (ExteNET Trial)
2016-07-21,Puma Biotechnology Submits New Drug Application For PB272 (Neratinib) To U.S. FDA For Extended Adjuvant Treatment Of HER2-Positive Early Stage Breast Cancer
2016-07-07,Puma Biotechnology Announces I-SPY 2 Phase II Study Of Neratinib Published In The New England Journal Of Medicine
2016-06-29,16 Biopharma Companies Besides Medivation That Are Attractive Targets
2016-06-29,'Mad Money' Lightning Round: I Like Sirius XM Radio
2016-06-28,Jim Cramer's 'Mad Money' Recap: Add These 2 Stocks to FANG
2016-06-27,Puma Biotechnology Submits Marketing Authorization Application For PB272 (Neratinib) As Extended Adjuvant Treatment Of HER2-Positive Early Stage Breast Cancer In Europe
2016-06-20,August 19th Options Now Available For Puma Biotechnology (PBYI)
2016-06-10,Short Interest Increases 11.8% For PBYI
2016-06-05,Puma Biotechnology Presents Positive Phase II Data At The 2016 ASCO Annual Meeting
2016-05-18,Puma Biotechnology Announces Publication Of Neratinib Abstract For The 2016 ASCO Annual Meeting
2016-05-17,Puma Biotechnology To Present At UBS Global Healthcare Conference
2016-05-12,July 1st Options Now Available For Puma Biotechnology (PBYI)
2016-05-10,Puma Biotechnology Reports First Quarter 2016 Financial Results
2016-05-04,Puma Biotechnology To Present At Bank Of America Merrill Lynch Health Care Conference
2016-04-20,Puma Biotechnology's Neratinib Featured In Poster Presentations At The AACR Annual Meeting 2016
2016-04-14,Puma Biotechnology's NEfERT-T Phase II Study Published Online In JAMA Oncology
2016-03-29,Puma Biotechnology (PBYI) Stock Plunges on Delayed Marketing Application
2016-03-28,Puma Biotechnology Updates Timeline For Filing New Drug Application
2016-03-18,Puma Biotechnology Announces Publication Of Abstracts On Neratinib For The AACR Annual Meeting 2016
2016-03-02,Puma Biotechnology To Present At Cowen's Health Care Conference
2016-02-29,Puma Biotechnology Reports Fourth Quarter And Full Year 2015 Financial Results
2016-02-17,Puma Biotechnology To Participate In Fireside Chat At RBC Capital Markets Global Healthcare Conference
2016-02-16,Puma Biotechnology Announces The Conclusion And Final Results Of Eshelman's Consent Solicitation
2016-02-11,Puma Biotechnology's ExteNET Phase III Study Published Online In The Lancet Oncology
2016-02-03,Puma Biotechnology To Participate In Fireside Chat At Leerink Partners Global Healthcare Conference
2016-01-22,Interesting PBYI Put And Call Options For September 16th
2016-01-14,Puma Biotechnology Stock Sees Short Interest Make 46% Move
2016-01-09,2016 Biotech Stock Prediction: It's Going to Be a Bummer Year, Folks
2016-01-08,Puma Biotechnology Shareholders Overwhelmingly Reject Eshelman's Consent Solicitation
2016-01-04,Puma Biotechnology To Present At J.P. Morgan Healthcare Conference
2016-01-01,Feuerstein's Heroes and Zeroes of Biotech Investing in 2015
2015-12-30,Third Independent Proxy Advisory Firm Recommends That Puma Biotechnology Shareholders Reject Eshelman's Consent Solicitation By REVOKING CONSENT On Puma's BLUE Consent Revocation Card
2015-12-29,Second Leading Independent Proxy Advisory Firm Recommends That Puma Biotechnology Shareholders Reject Eshelman's Consent Solicitation By REVOKING CONSENT On Puma's BLUE Consent Revocation Card
2015-12-23,ISS Recommends That Puma Biotechnology Shareholders Reject Eshelman's Consent Solicitation By REVOKING CONSENT On Puma's BLUE Consent Revocation Card
2015-12-18,Puma Biotechnology Expands Third Cohort In Phase II Trial Of PB272 In HER2 Mutation Positive Cancer Patients
2015-12-16,Puma Biotechnology To Host Conference Call To Discuss Loperamide Prophylaxis To Reduce Neratinib-Related Diarrhea
2015-12-15,8 Stocks Spiking on Unusually High Volume
2015-12-11,Puma Biotechnology Presents 3-Year Disease Free Survival Data From Phase III Trial Of PB272 In Extended Adjuvant Breast Cancer (ExteNET Trial) At The 2015 San Antonio Breast Cancer Symposium
2015-12-10,Puma Biotechnology Presents Interim Results Of Phase II Trial Of PB272 For ERBB2 Mutant, HER2 Non-Amplified, Metastatic Breast Cancer At The 2015 San Antonio Breast Cancer Symposium
2015-12-10,Puma Biotechnology Announces Results Of Phase II Trial Of PB272 In Neoadjuvant Treatment Of HER2-Positive Locally Advanced Breast Cancer
2015-11-30,Puma Biotechnology Provides Update From Meeting With European Medicines Agency
2015-11-13,Puma Biotechnology To Present Data At The San Antonio Breast Cancer Symposium (SABCS)
2015-11-09,Puma Biotechnology Reports Third Quarter 2015 Financial Results
2015-11-03,Puma Biotechnology To Present At Credit Suisse Healthcare Conference
2015-09-26,Puma Biotechnology Announces Presentation Of Phase III Trial Of PB272 In Extended Adjuvant Breast Cancer (ExteNET Trial) In Centrally Confirmed HER2-Positive Early Stage Breast Cancer Patients
2015-09-10,Puma Biotechnology Announces Publication Of PB272 In HER2 Non-Amplified Metastatic Breast Cancer With A HER2 Mutation
2015-09-04,Battleground: Will This $5 Biotech Stock Go To $22 Or $1.50?
2015-09-03,Jim Cramer's Top Takeaways: Puma Biotechnology and H&R Block
2015-09-02,Jim Cramer's 'Mad Money' Recap: A Rally or Calm Before the Storm?
2015-08-10,Puma Biotechnology Reports Second Quarter 2015 Financial Results
2015-08-10,August 10 Premarket Briefing: 10 Things You Should Know
2015-07-31,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Puma Biotechnology, Inc. Of Pendency Of Class Action Lawsuit And A Lead Plaintiff Deadline Of August 3, 2015 - PBYI
2015-07-24,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Puma Biotechnology, Inc. Of Pendency Of Class Action Lawsuit And A Lead Plaintiff Deadline Of August 3, 2015 - PBYI
2015-07-20,Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors Of Class Action Against Puma Biotechnology, Inc. And Lead Plaintiff Deadline Of August 3, 2015
2015-07-11,'Mad Money' Lightning Round: Stay Away From Barracuda Networks
2015-07-10,Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
2015-07-03,SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Puma Biotechnology, Inc. Of Class Action Lawsuit And Upcoming Deadline - PBYI
2015-07-02,Biotech Stock Mailbag: Grading 2015 Biotech Predictions at the Halfway Point
2015-06-26,IMPORTANT INVESTOR DEADLINE: Goldberg Law PC Reminds Investors With Losses Greater Than $100,000 In Puma Biotechnology, Inc. Of The August 3, 2015 Deadline
2015-06-26,Biotech Stock Mailbag: Exelixis, Puma Bio
2015-06-23,Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Puma Biotechnology, Inc.
2015-06-22,Harwood Feffer LLP Announces Securities Class Action Lawsuit Against Puma Biotechnology, Inc. And Advises Shareholders To Contact Harwood Feffer LLP Prior To The Lead Plaintiff Deadline
2015-06-05,Biotech Stock Mailbag: More Duchenne Drama, CAR-T Trouble, ASCO '15 Rewind
2015-06-04,Puma Biotechnology To Present At Goldman Sachs Healthcare Conference
2015-06-04,Top-Performing Biotech and Drug Stocks During ASCO '15
2015-06-01,Puma Bio Breast Cancer Drug Given Rough Treatment at ASCO '15
2015-06-01,Puma Biotechnology Investors Encouraged To Contact Securities Law Firm About Investigation Into Allegations Of Corporate Wrongdoing
2015-06-01,Puma Biotechnology Announces Phase III Trial Of PB272 In Extended Adjuvant Breast Cancer (ExteNET Trial) Demonstrates Statistically Significant Improvement In Disease Free Survival
2015-06-01,Puma Biotech Hoping for a Bounce at Annual Meeting of Cancer Society
2015-06-01,ASCO '15 Report Card: Grading Biotech and Drug Stocks at Cancer Drug Confab
2015-06-01,Cancer Breakthroughs Expected at Annual Meeting of Cancer Society
2015-06-01,Oncothyreon Breast Cancer Drug Exits ASCO '15 With Good Buzz
2015-05-29,Fly Watch: Several Names That May Move Following ASCO Meeting
2015-05-28,Puma Bio Restricting Access to Breast Cancer Event at ASCO Chicago
2015-05-27,Puma Biotechnology To Present At Jefferies 2015 Healthcare Conference
2015-05-22,Biotech Stock Mailbag: ASCO Preview, CAR-T stocks, MannKind, Hate Mail!
2015-05-15,6 Stocks Spiking on Big Volume
2015-05-14,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Puma Biotechnology, Inc.
2015-05-14,Walmart Stores Is Working on a Rival to Amazon's Prime Service
2015-05-13,Puma Biotechnology Announces Publication Of Abstracts For The 2015 American Society Of Clinical Oncology (ASCO) Annual Meeting
2015-05-13,Jumpstart ASCO '15 With This Quick List of Hot Research Abstracts
2015-05-12,Puma Biotechnology To Participate In Fireside Chat At UBS Global Healthcare Conference
2015-05-11,Puma Biotechnology Reports First Quarter 2015 Financial Results
2015-05-06,Puma Biotechnology To Present At Bank Of America Merrill Lynch Health Care Conference
2015-04-30,Puma Biotechnology To Present At Deutsche Bank Health Care Conference
2015-04-27,Puma Biotechnology Larger Than S&P 500 Component Mallinckrodt
2015-04-14,Puma Biotechnology Expands Cohort In Phase II Trial Of PB272 In HER2 Mutation Positive Cancer Patients
2015-03-10,Puma Biotechnology Initiates Phase II Trial Of PB272 In Early Stage HER2-Positive Breast Cancer
2015-03-06,Biotech Stock Mailbag: Next Biotech Takeout Targets, NewLink Genetics
2015-03-05,Market News: Mallinckrodt, Kroger, Puma Biotechnology
2015-03-02,Puma Biotechnology Reports Fourth Quarter And Full Year 2014 Financial Results
2015-02-24,Puma Biotechnology To Present At Cowen Health Care Conference
2015-02-18,Puma Biotechnology To Participate In Fireside Chat At RBC Capital Markets' Global Healthcare Conference
2015-02-10,Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Puma Biotechnology, Inc.
2015-02-09,INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Puma Biotechnology, Inc. (PBYI) To Contact The Firm
2015-02-05,Puma Biotechnology To Present At Leerink Global Healthcare Conference
2015-01-27,Puma Biotechnology Closes $218 Million Public Offering Of Common Stock
2015-01-22,Puma Biotechnology Announces Underwriters' Full Exercise Of Option To Purchase Additional Shares
2015-01-22,4 Stocks Spiking on Unusual Volume: Puma Biotech, Nexstar and More
2015-01-21,Puma Biotechnology Prices Public Offering Of Common Stock
2015-01-20,Puma Biotechnology Announces Proposed Public Offering
2015-01-08,The Best And Worst Analyst Recommendations Of 2014
2015-01-06,Fifteen Fabulously Intelligent Biotech Stock Predictions for 2015
2015-01-05,Puma Biotechnology To Present At J.P. Morgan Healthcare Conference
2014-12-12,Puma Biotechnology Announces Positive Interim PB272 (Neratinib) Phase II Data At 2014 CTRC-AACR San Antonio Breast Cancer Symposium
2014-12-10,SHAREHOLDER ALERT: The Law Firm Of Levi & Korsinsky, LLP Launches An Investigation Into Possible Violations Of Federal Securities Laws By The Board Of Directors Of Puma Biotechnology, Inc.
2014-12-04,Lifshitz & Miller Law Firm Announces Investigation Of Avanir Pharmaceuticals, Inc., Carbonite, Inc., Casey's General Stores, Inc., Nymox Pharmaceutical Corporation, Puma Biotechnology Inc., RealD Inc., And Spansion, Inc.
2014-12-03,Stocks Close Higher, Helped by Continued Strength in Economy
2014-12-03,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Puma Biotechnology, Inc.
2014-12-03,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Puma Biotechnology, Inc. - PBYI
2014-12-03,Stocks Trade Higher as Services Sector Grows More Than Expected
2014-12-02,Puma Forced to Delay Breast Cancer FDA Submission Due to New Safety Data Requirement
2014-12-02,Puma Biotechnology Updates Timeline For Filing New Drug Application
2014-11-25,One Solution to the Growth vs. Value Debate: Combine Them
2014-11-21,Biotech Stock Mailbag: Northwest Bio, Celldex, Puma, MannKind
2014-11-13,Puma Biotechnology Announces Positive Top Line Results From PB272 Phase II Trial In HER2 Positive Metastatic Breast Cancer (NEfERTT Trial)
2014-11-12,Puma Biotechnology To Present At Stifel 2014 Healthcare Conference
2014-11-10,Puma Biotechnology Reports Third Quarter 2014 Financial Results
2017-03-20,Finding Bullish and Bearish Market Reversals
2017-03-12,Biotechs Among 5 Stocks Setting Up for Major Breakouts
2017-03-10,Biotech Stock Mailbag: Puma's Rebound Explained, TG Therapeutics Approval Debate, Aurinia Next Steps
2017-03-09,These Stocks Are Trending Up With Monster Volume
2017-03-09,7 Stocks Trending Up With Monster Volume
2017-03-02,Puma Biotechnology To Present At Cowen's Health Care Conference
2017-03-02,Dow Declines, Caterpillar Weighs on Index as Feds Swarm Offices
2017-03-02,Stocks Slide as Rally Runs Out of Steam; Snap Makes Trading Debut
2017-03-02,Biotech Premarket Movers: Aurinia, Puma, PTC, Juno
2017-03-02,What You Need to Know About Roche AG's Breast Cancer Drug Perjeta
2017-03-02,Roche Shares Soar, Puma Bio Sinks on Perjeta Breast Cancer Study Win
2017-03-01,Puma Biotechnology Announces Publication Of Abstracts On Neratinib For The AACR Annual Meeting 2017
2017-03-01,Puma Biotechnology Provides Update On Review Of Marketing Authorisation Application For PB272
2017-03-01,Puma Biotechnology Reports Fourth Quarter And Full Year 2016 Financial Results
2017-02-14,Puma Biotechnology To Present At RBC Capital Markets Healthcare Conference
2017-02-08,Puma Biotechnology To Present At LEERINK Partners Global Healthcare Conference
2017-02-03,Biotech Stock Mailbag: Do Investors Have an 'Aphinity' for Shorting Puma Into Trial Results?
2017-01-09,Newman Ferrara LLP Announces Corporate Governance Investigation Of Puma Biotechnology, Inc. - PBYI
2017-01-06,Puma Biotechnology Expands Cohort In Phase II SUMMIT Trial Of PB272 In HER2 Mutation-Positive Cancer Patients
2017-01-03,Puma Biotechnology To Present At J.P. Morgan Healthcare Conference
2017-01-03,17 Thoughts on Biotech Stocks to Kick Off 2017
2016-12-22,What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016
2016-12-20,First Week of PBYI February 2017 Options Trading
2016-12-19,Puma Biotechnology To Move Stock Exchange Listing To Nasdaq
2016-12-08,Figure 1: Treatment Emergent Diarrhea By Month In ExteNET Versus CONTROL (Graphic: Business Wire)
2016-12-07,Puma Biotechnology Presents Results Of Biomarker Analysis Of Phase II Trial Of PB272 In Neoadjuvant Treatment Of HER2-Positive Locally Advanced Breast Cancer At The 2016 San Antonio Breast Cancer Symposium
2016-12-07,Puma Biotechnology Presents Interim Results Of Phase II Trial Of PB272 For ERBB2 (HER2) Mutant, HER2 Non-Amplified, Metastatic Breast Cancer At The 2016 San Antonio Breast Cancer Symposium
2016-12-07,Cascadian Therapeutics Enlarges Breast Cancer Pill Study to Meet FDA Registration Standards
2016-12-06,Puma Biotechnology Initiates A Managed Access Program For PB272 (Neratinib) Outside The United States
2016-11-15,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Puma Biotechnology, Inc. (PBYI)
2016-11-15,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Puma Biotechnology, Inc. - PBYI
2016-11-14,Puma Biotechnology Announces Presentations Of Investigational Data At The San Antonio Breast Cancer Symposium (SABCS)
2016-11-14,Puma Bio Falls on Escalating Concerns About Diarrhea Risk With Breast Cancer Drug
2016-11-11,Puma Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Puma Biotechnology, Inc. - PBYI
2016-11-09,Puma Biotechnology Reports Third Quarter 2016 Financial Results
2016-10-31,Puma Biotechnology To Present At Credit Suisse Healthcare Conference
2016-10-31,Lifshitz & Miller Law Firm Announces Investigation Of Electronics For Imaging, Inc., Ferrellgas Partners LP, Fusion Pharm, Inc., Humana Inc., KemPharm, Inc., National Beverage Corp., Puma Biotechnology, Inc., And TG Therapeutics, Inc.
2016-10-28,PUMA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Puma Biotechnology, Inc. - PBYI
2016-10-25,Puma Biotechnology Closes $172 Million Public Offering Of Common Stock
2016-10-24,June 2017 Options Now Available For Puma Biotechnology (PBYI)
2016-10-21,Puma Biotechnology Announces Underwriters' Full Exercise Of Option To Purchase Additional Shares
2016-10-20,Puma Bio's Desperate Money Grab Signals Breast Cancer Drug Trouble
2016-10-19,Puma Biotechnology Prices Public Offering Of Common Stock
2016-10-18,Puma Biotechnology (PBYI) Stock Down in After-Hours Trading on Public Offering
2016-10-18,Puma Biotechnology Announces Proposed Public Offering Of Common Stock
2016-10-14,PUMA INVESTIGATION INITIATED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Puma Biotechnology, Inc. - PBYI
2016-10-12,Robbins Arroyo LLP: Puma Biotechnology, Inc. (PBYI) Investors Survive Defendants' Motion To Dismiss In Securities Class Action
2016-10-11,Puma Biotechnology, Inc. Shareholder Alert: Schubert Firm Investigates Company's Top Executives
2016-10-10,Johnson & Weaver, LLP Initiates Investigations Of Puma Biotechnology, Inc., Virtus Investment Partners, Inc., AAC Holdings, Inc. And Spectrum Pharmaceuticals, Inc.; Encourages Long-Term Investors To Contact The Firm Regarding Their Legal Rights
2016-09-30,Biotech Stock Mailbag: Dynavax, Puma, Ariad
2016-09-22,Puma Biotechnology Shares Leap Forward
2016-09-20,Why Puma Biotechnology (PBYI) Stock Is Surging Today
2016-09-20,Puma Biotechnology Announces U.S. FDA Acceptance Of New Drug Application For PB272 (Neratinib) For Extended Adjuvant Treatment Of HER2-Positive Early Stage Breast Cancer
2016-09-02,Jim Cramer's Top Takeaways: Salesforce.com, GCP Applied Technologies, Puma Biotechnology
2016-09-01,Jim Cramer's 'Mad Money' Recap: What Is Going on With This Market?
2016-08-24,Noteworthy Wednesday Option Activity: PBYI, MOV, BOFI
2016-08-23,4 Biotech Stock Charts You Must See
2016-08-22,Puma Biotechnology Announces European Medicines Agency Validation Of Marketing Authorization Application For PB272 (Neratinib) As Extended Adjuvant Treatment Of HER2-Positive Early Stage Breast Cancer In Europe
2016-08-09,Puma Biotechnology Reports Second Quarter 2016 Financial Results
2016-07-29,Biotech Stock Mailbag: Puma Roars, Relypsa Soars, XBiotech Bombs
2016-07-22,Morning Movers: GE, AMD, P, PBYI
2016-07-21,Puma Biotechnology Announces Interim 5-Year Disease Free Survival Data From Phase III Trial Of PB272 (Neratinib) In Extended Adjuvant HER2-Positive Early Stage Breast Cancer (ExteNET Trial)
2016-07-21,Puma Biotechnology Submits New Drug Application For PB272 (Neratinib) To U.S. FDA For Extended Adjuvant Treatment Of HER2-Positive Early Stage Breast Cancer
2016-07-07,Puma Biotechnology Announces I-SPY 2 Phase II Study Of Neratinib Published In The New England Journal Of Medicine
2016-06-29,16 Biopharma Companies Besides Medivation That Are Attractive Targets
2016-06-29,'Mad Money' Lightning Round: I Like Sirius XM Radio
2016-06-28,Jim Cramer's 'Mad Money' Recap: Add These 2 Stocks to FANG
2016-06-27,Puma Biotechnology Submits Marketing Authorization Application For PB272 (Neratinib) As Extended Adjuvant Treatment Of HER2-Positive Early Stage Breast Cancer In Europe
2016-06-20,August 19th Options Now Available For Puma Biotechnology (PBYI)
2016-06-10,Short Interest Increases 11.8% For PBYI
2016-06-05,Puma Biotechnology Presents Positive Phase II Data At The 2016 ASCO Annual Meeting
2016-05-18,Puma Biotechnology Announces Publication Of Neratinib Abstract For The 2016 ASCO Annual Meeting
2016-05-17,Puma Biotechnology To Present At UBS Global Healthcare Conference
2016-05-12,July 1st Options Now Available For Puma Biotechnology (PBYI)
2016-05-10,Puma Biotechnology Reports First Quarter 2016 Financial Results
2016-05-04,Puma Biotechnology To Present At Bank Of America Merrill Lynch Health Care Conference
2016-04-20,Puma Biotechnology's Neratinib Featured In Poster Presentations At The AACR Annual Meeting 2016
2016-04-14,Puma Biotechnology's NEfERT-T Phase II Study Published Online In JAMA Oncology
2016-03-29,Puma Biotechnology (PBYI) Stock Plunges on Delayed Marketing Application
2016-03-28,Puma Biotechnology Updates Timeline For Filing New Drug Application
2016-03-18,Puma Biotechnology Announces Publication Of Abstracts On Neratinib For The AACR Annual Meeting 2016
2016-03-02,Puma Biotechnology To Present At Cowen's Health Care Conference
2016-02-29,Puma Biotechnology Reports Fourth Quarter And Full Year 2015 Financial Results
2016-02-17,Puma Biotechnology To Participate In Fireside Chat At RBC Capital Markets Global Healthcare Conference
2016-02-16,Puma Biotechnology Announces The Conclusion And Final Results Of Eshelman's Consent Solicitation
2016-02-11,Puma Biotechnology's ExteNET Phase III Study Published Online In The Lancet Oncology
2016-02-03,Puma Biotechnology To Participate In Fireside Chat At Leerink Partners Global Healthcare Conference
2016-01-22,Interesting PBYI Put And Call Options For September 16th
2016-01-14,Puma Biotechnology Stock Sees Short Interest Make 46% Move
2016-01-09,2016 Biotech Stock Prediction: It's Going to Be a Bummer Year, Folks
2016-01-08,Puma Biotechnology Shareholders Overwhelmingly Reject Eshelman's Consent Solicitation
2016-01-04,Puma Biotechnology To Present At J.P. Morgan Healthcare Conference
2016-01-01,Feuerstein's Heroes and Zeroes of Biotech Investing in 2015
2015-12-30,Third Independent Proxy Advisory Firm Recommends That Puma Biotechnology Shareholders Reject Eshelman's Consent Solicitation By REVOKING CONSENT On Puma's BLUE Consent Revocation Card
2015-12-29,Second Leading Independent Proxy Advisory Firm Recommends That Puma Biotechnology Shareholders Reject Eshelman's Consent Solicitation By REVOKING CONSENT On Puma's BLUE Consent Revocation Card
2015-12-23,ISS Recommends That Puma Biotechnology Shareholders Reject Eshelman's Consent Solicitation By REVOKING CONSENT On Puma's BLUE Consent Revocation Card
2015-12-18,Puma Biotechnology Expands Third Cohort In Phase II Trial Of PB272 In HER2 Mutation Positive Cancer Patients
2015-12-16,Puma Biotechnology To Host Conference Call To Discuss Loperamide Prophylaxis To Reduce Neratinib-Related Diarrhea
2015-12-15,8 Stocks Spiking on Unusually High Volume
2015-12-11,Puma Biotechnology Presents 3-Year Disease Free Survival Data From Phase III Trial Of PB272 In Extended Adjuvant Breast Cancer (ExteNET Trial) At The 2015 San Antonio Breast Cancer Symposium
2015-12-10,Puma Biotechnology Presents Interim Results Of Phase II Trial Of PB272 For ERBB2 Mutant, HER2 Non-Amplified, Metastatic Breast Cancer At The 2015 San Antonio Breast Cancer Symposium
2015-12-10,Puma Biotechnology Announces Results Of Phase II Trial Of PB272 In Neoadjuvant Treatment Of HER2-Positive Locally Advanced Breast Cancer
2015-11-30,Puma Biotechnology Provides Update From Meeting With European Medicines Agency
2015-11-13,Puma Biotechnology To Present Data At The San Antonio Breast Cancer Symposium (SABCS)
2015-11-09,Puma Biotechnology Reports Third Quarter 2015 Financial Results
2015-11-03,Puma Biotechnology To Present At Credit Suisse Healthcare Conference
2015-09-26,Puma Biotechnology Announces Presentation Of Phase III Trial Of PB272 In Extended Adjuvant Breast Cancer (ExteNET Trial) In Centrally Confirmed HER2-Positive Early Stage Breast Cancer Patients
2015-09-10,Puma Biotechnology Announces Publication Of PB272 In HER2 Non-Amplified Metastatic Breast Cancer With A HER2 Mutation
2015-09-04,Battleground: Will This $5 Biotech Stock Go To $22 Or $1.50?
2015-09-03,Jim Cramer's Top Takeaways: Puma Biotechnology and H&R Block
2015-09-02,Jim Cramer's 'Mad Money' Recap: A Rally or Calm Before the Storm?
2015-08-10,Puma Biotechnology Reports Second Quarter 2015 Financial Results
2015-08-10,August 10 Premarket Briefing: 10 Things You Should Know
2015-07-31,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Puma Biotechnology, Inc. Of Pendency Of Class Action Lawsuit And A Lead Plaintiff Deadline Of August 3, 2015 - PBYI
2015-07-24,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Puma Biotechnology, Inc. Of Pendency Of Class Action Lawsuit And A Lead Plaintiff Deadline Of August 3, 2015 - PBYI
2015-07-20,Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors Of Class Action Against Puma Biotechnology, Inc. And Lead Plaintiff Deadline Of August 3, 2015
2015-07-11,'Mad Money' Lightning Round: Stay Away From Barracuda Networks
2015-07-10,Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
2015-07-03,SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Puma Biotechnology, Inc. Of Class Action Lawsuit And Upcoming Deadline - PBYI
2015-07-02,Biotech Stock Mailbag: Grading 2015 Biotech Predictions at the Halfway Point
2015-06-26,IMPORTANT INVESTOR DEADLINE: Goldberg Law PC Reminds Investors With Losses Greater Than $100,000 In Puma Biotechnology, Inc. Of The August 3, 2015 Deadline
2015-06-26,Biotech Stock Mailbag: Exelixis, Puma Bio
2015-06-23,Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Puma Biotechnology, Inc.
2015-06-22,Harwood Feffer LLP Announces Securities Class Action Lawsuit Against Puma Biotechnology, Inc. And Advises Shareholders To Contact Harwood Feffer LLP Prior To The Lead Plaintiff Deadline
2015-06-05,Biotech Stock Mailbag: More Duchenne Drama, CAR-T Trouble, ASCO '15 Rewind
2015-06-04,Puma Biotechnology To Present At Goldman Sachs Healthcare Conference
2015-06-04,Top-Performing Biotech and Drug Stocks During ASCO '15
2015-06-01,Puma Bio Breast Cancer Drug Given Rough Treatment at ASCO '15
2015-06-01,Puma Biotechnology Investors Encouraged To Contact Securities Law Firm About Investigation Into Allegations Of Corporate Wrongdoing
2015-06-01,Puma Biotechnology Announces Phase III Trial Of PB272 In Extended Adjuvant Breast Cancer (ExteNET Trial) Demonstrates Statistically Significant Improvement In Disease Free Survival
2015-06-01,Puma Biotech Hoping for a Bounce at Annual Meeting of Cancer Society
2015-06-01,ASCO '15 Report Card: Grading Biotech and Drug Stocks at Cancer Drug Confab
2015-06-01,Cancer Breakthroughs Expected at Annual Meeting of Cancer Society
2015-06-01,Oncothyreon Breast Cancer Drug Exits ASCO '15 With Good Buzz
2015-05-29,Fly Watch: Several Names That May Move Following ASCO Meeting
2015-05-28,Puma Bio Restricting Access to Breast Cancer Event at ASCO Chicago
2015-05-27,Puma Biotechnology To Present At Jefferies 2015 Healthcare Conference
2015-05-22,Biotech Stock Mailbag: ASCO Preview, CAR-T stocks, MannKind, Hate Mail!
2015-05-15,6 Stocks Spiking on Big Volume
2015-05-14,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Puma Biotechnology, Inc.
2015-05-14,Walmart Stores Is Working on a Rival to Amazon's Prime Service
2015-05-13,Puma Biotechnology Announces Publication Of Abstracts For The 2015 American Society Of Clinical Oncology (ASCO) Annual Meeting
2015-05-13,Jumpstart ASCO '15 With This Quick List of Hot Research Abstracts
2015-05-12,Puma Biotechnology To Participate In Fireside Chat At UBS Global Healthcare Conference
2015-05-11,Puma Biotechnology Reports First Quarter 2015 Financial Results
2015-05-06,Puma Biotechnology To Present At Bank Of America Merrill Lynch Health Care Conference
2015-04-30,Puma Biotechnology To Present At Deutsche Bank Health Care Conference
2015-04-27,Puma Biotechnology Larger Than S&P 500 Component Mallinckrodt
2015-04-14,Puma Biotechnology Expands Cohort In Phase II Trial Of PB272 In HER2 Mutation Positive Cancer Patients
2015-03-10,Puma Biotechnology Initiates Phase II Trial Of PB272 In Early Stage HER2-Positive Breast Cancer
2015-03-06,Biotech Stock Mailbag: Next Biotech Takeout Targets, NewLink Genetics
2015-03-05,Market News: Mallinckrodt, Kroger, Puma Biotechnology
2015-03-02,Puma Biotechnology Reports Fourth Quarter And Full Year 2014 Financial Results
2015-02-24,Puma Biotechnology To Present At Cowen Health Care Conference
2015-02-18,Puma Biotechnology To Participate In Fireside Chat At RBC Capital Markets' Global Healthcare Conference
2015-02-10,Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Puma Biotechnology, Inc.
2015-02-09,INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Puma Biotechnology, Inc. (PBYI) To Contact The Firm
2015-02-05,Puma Biotechnology To Present At Leerink Global Healthcare Conference
2015-01-27,Puma Biotechnology Closes $218 Million Public Offering Of Common Stock
2015-01-22,Puma Biotechnology Announces Underwriters' Full Exercise Of Option To Purchase Additional Shares
2015-01-22,4 Stocks Spiking on Unusual Volume: Puma Biotech, Nexstar and More
2015-01-21,Puma Biotechnology Prices Public Offering Of Common Stock
2015-01-20,Puma Biotechnology Announces Proposed Public Offering
2015-01-08,The Best And Worst Analyst Recommendations Of 2014
2015-01-06,Fifteen Fabulously Intelligent Biotech Stock Predictions for 2015
2015-01-05,Puma Biotechnology To Present At J.P. Morgan Healthcare Conference
2014-12-12,Puma Biotechnology Announces Positive Interim PB272 (Neratinib) Phase II Data At 2014 CTRC-AACR San Antonio Breast Cancer Symposium
2014-12-10,SHAREHOLDER ALERT: The Law Firm Of Levi & Korsinsky, LLP Launches An Investigation Into Possible Violations Of Federal Securities Laws By The Board Of Directors Of Puma Biotechnology, Inc.
2014-12-04,Lifshitz & Miller Law Firm Announces Investigation Of Avanir Pharmaceuticals, Inc., Carbonite, Inc., Casey's General Stores, Inc., Nymox Pharmaceutical Corporation, Puma Biotechnology Inc., RealD Inc., And Spansion, Inc.
2014-12-03,Stocks Close Higher, Helped by Continued Strength in Economy
2014-12-03,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Puma Biotechnology, Inc.
2014-12-03,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Puma Biotechnology, Inc. - PBYI
2014-12-03,Stocks Trade Higher as Services Sector Grows More Than Expected
2014-12-02,Puma Forced to Delay Breast Cancer FDA Submission Due to New Safety Data Requirement
2014-12-02,Puma Biotechnology Updates Timeline For Filing New Drug Application
2014-11-25,One Solution to the Growth vs. Value Debate: Combine Them
2014-11-21,Biotech Stock Mailbag: Northwest Bio, Celldex, Puma, MannKind
2014-11-13,Puma Biotechnology Announces Positive Top Line Results From PB272 Phase II Trial In HER2 Positive Metastatic Breast Cancer (NEfERTT Trial)
2014-11-12,Puma Biotechnology To Present At Stifel 2014 Healthcare Conference
2014-11-10,Puma Biotechnology Reports Third Quarter 2014 Financial Results
2017-03-20,Finding Bullish and Bearish Market Reversals
2017-03-12,Biotechs Among 5 Stocks Setting Up for Major Breakouts
2017-03-10,Biotech Stock Mailbag: Puma's Rebound Explained, TG Therapeutics Approval Debate, Aurinia Next Steps
2017-03-09,These Stocks Are Trending Up With Monster Volume
2017-03-09,7 Stocks Trending Up With Monster Volume
2017-03-02,Puma Biotechnology To Present At Cowen's Health Care Conference
2017-03-02,Dow Declines, Caterpillar Weighs on Index as Feds Swarm Offices
2017-03-02,Stocks Slide as Rally Runs Out of Steam; Snap Makes Trading Debut
2017-03-02,Biotech Premarket Movers: Aurinia, Puma, PTC, Juno
2017-03-02,What You Need to Know About Roche AG's Breast Cancer Drug Perjeta
2017-03-02,Roche Shares Soar, Puma Bio Sinks on Perjeta Breast Cancer Study Win
2017-03-01,Puma Biotechnology Announces Publication Of Abstracts On Neratinib For The AACR Annual Meeting 2017
2017-03-01,Puma Biotechnology Provides Update On Review Of Marketing Authorisation Application For PB272
2017-03-01,Puma Biotechnology Reports Fourth Quarter And Full Year 2016 Financial Results
2017-02-14,Puma Biotechnology To Present At RBC Capital Markets Healthcare Conference
2017-02-08,Puma Biotechnology To Present At LEERINK Partners Global Healthcare Conference
2017-02-03,Biotech Stock Mailbag: Do Investors Have an 'Aphinity' for Shorting Puma Into Trial Results?
2017-01-09,Newman Ferrara LLP Announces Corporate Governance Investigation Of Puma Biotechnology, Inc. - PBYI
2017-01-06,Puma Biotechnology Expands Cohort In Phase II SUMMIT Trial Of PB272 In HER2 Mutation-Positive Cancer Patients
2017-01-03,Puma Biotechnology To Present At J.P. Morgan Healthcare Conference
2017-01-03,17 Thoughts on Biotech Stocks to Kick Off 2017
2016-12-22,What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016
2016-12-20,First Week of PBYI February 2017 Options Trading
2016-12-19,Puma Biotechnology To Move Stock Exchange Listing To Nasdaq
2016-12-08,Figure 1: Treatment Emergent Diarrhea By Month In ExteNET Versus CONTROL (Graphic: Business Wire)
2016-12-07,Puma Biotechnology Presents Results Of Biomarker Analysis Of Phase II Trial Of PB272 In Neoadjuvant Treatment Of HER2-Positive Locally Advanced Breast Cancer At The 2016 San Antonio Breast Cancer Symposium
2016-12-07,Puma Biotechnology Presents Interim Results Of Phase II Trial Of PB272 For ERBB2 (HER2) Mutant, HER2 Non-Amplified, Metastatic Breast Cancer At The 2016 San Antonio Breast Cancer Symposium
2016-12-07,Cascadian Therapeutics Enlarges Breast Cancer Pill Study to Meet FDA Registration Standards
2016-12-06,Puma Biotechnology Initiates A Managed Access Program For PB272 (Neratinib) Outside The United States
2016-11-15,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Puma Biotechnology, Inc. (PBYI)
2016-11-15,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Puma Biotechnology, Inc. - PBYI
2016-11-14,Puma Biotechnology Announces Presentations Of Investigational Data At The San Antonio Breast Cancer Symposium (SABCS)
2016-11-14,Puma Bio Falls on Escalating Concerns About Diarrhea Risk With Breast Cancer Drug
2016-11-11,Puma Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Puma Biotechnology, Inc. - PBYI
2016-11-09,Puma Biotechnology Reports Third Quarter 2016 Financial Results
2016-10-31,Puma Biotechnology To Present At Credit Suisse Healthcare Conference
2016-10-31,Lifshitz & Miller Law Firm Announces Investigation Of Electronics For Imaging, Inc., Ferrellgas Partners LP, Fusion Pharm, Inc., Humana Inc., KemPharm, Inc., National Beverage Corp., Puma Biotechnology, Inc., And TG Therapeutics, Inc.
2016-10-28,PUMA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Puma Biotechnology, Inc. - PBYI
2016-10-25,Puma Biotechnology Closes $172 Million Public Offering Of Common Stock
2016-10-24,June 2017 Options Now Available For Puma Biotechnology (PBYI)
2016-10-21,Puma Biotechnology Announces Underwriters' Full Exercise Of Option To Purchase Additional Shares
2016-10-20,Puma Bio's Desperate Money Grab Signals Breast Cancer Drug Trouble
2016-10-19,Puma Biotechnology Prices Public Offering Of Common Stock
2016-10-18,Puma Biotechnology (PBYI) Stock Down in After-Hours Trading on Public Offering
2016-10-18,Puma Biotechnology Announces Proposed Public Offering Of Common Stock
2016-10-14,PUMA INVESTIGATION INITIATED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Puma Biotechnology, Inc. - PBYI
2016-10-12,Robbins Arroyo LLP: Puma Biotechnology, Inc. (PBYI) Investors Survive Defendants' Motion To Dismiss In Securities Class Action
2016-10-11,Puma Biotechnology, Inc. Shareholder Alert: Schubert Firm Investigates Company's Top Executives
2016-10-10,Johnson & Weaver, LLP Initiates Investigations Of Puma Biotechnology, Inc., Virtus Investment Partners, Inc., AAC Holdings, Inc. And Spectrum Pharmaceuticals, Inc.; Encourages Long-Term Investors To Contact The Firm Regarding Their Legal Rights
2016-09-30,Biotech Stock Mailbag: Dynavax, Puma, Ariad
2016-09-22,Puma Biotechnology Shares Leap Forward
2016-09-20,Why Puma Biotechnology (PBYI) Stock Is Surging Today
2016-09-20,Puma Biotechnology Announces U.S. FDA Acceptance Of New Drug Application For PB272 (Neratinib) For Extended Adjuvant Treatment Of HER2-Positive Early Stage Breast Cancer
2016-09-02,Jim Cramer's Top Takeaways: Salesforce.com, GCP Applied Technologies, Puma Biotechnology
2016-09-01,Jim Cramer's 'Mad Money' Recap: What Is Going on With This Market?
2016-08-24,Noteworthy Wednesday Option Activity: PBYI, MOV, BOFI
2016-08-23,4 Biotech Stock Charts You Must See
2016-08-22,Puma Biotechnology Announces European Medicines Agency Validation Of Marketing Authorization Application For PB272 (Neratinib) As Extended Adjuvant Treatment Of HER2-Positive Early Stage Breast Cancer In Europe
2016-08-09,Puma Biotechnology Reports Second Quarter 2016 Financial Results
2016-07-29,Biotech Stock Mailbag: Puma Roars, Relypsa Soars, XBiotech Bombs
2016-07-22,Morning Movers: GE, AMD, P, PBYI
2016-07-21,Puma Biotechnology Announces Interim 5-Year Disease Free Survival Data From Phase III Trial Of PB272 (Neratinib) In Extended Adjuvant HER2-Positive Early Stage Breast Cancer (ExteNET Trial)
2016-07-21,Puma Biotechnology Submits New Drug Application For PB272 (Neratinib) To U.S. FDA For Extended Adjuvant Treatment Of HER2-Positive Early Stage Breast Cancer
2016-07-07,Puma Biotechnology Announces I-SPY 2 Phase II Study Of Neratinib Published In The New England Journal Of Medicine
2016-06-29,16 Biopharma Companies Besides Medivation That Are Attractive Targets
2016-06-29,'Mad Money' Lightning Round: I Like Sirius XM Radio
2016-06-28,Jim Cramer's 'Mad Money' Recap: Add These 2 Stocks to FANG
2016-06-27,Puma Biotechnology Submits Marketing Authorization Application For PB272 (Neratinib) As Extended Adjuvant Treatment Of HER2-Positive Early Stage Breast Cancer In Europe
2016-06-20,August 19th Options Now Available For Puma Biotechnology (PBYI)
2016-06-10,Short Interest Increases 11.8% For PBYI
2016-06-05,Puma Biotechnology Presents Positive Phase II Data At The 2016 ASCO Annual Meeting
2016-05-18,Puma Biotechnology Announces Publication Of Neratinib Abstract For The 2016 ASCO Annual Meeting
2016-05-17,Puma Biotechnology To Present At UBS Global Healthcare Conference
2016-05-12,July 1st Options Now Available For Puma Biotechnology (PBYI)
2016-05-10,Puma Biotechnology Reports First Quarter 2016 Financial Results
2016-05-04,Puma Biotechnology To Present At Bank Of America Merrill Lynch Health Care Conference
2016-04-20,Puma Biotechnology's Neratinib Featured In Poster Presentations At The AACR Annual Meeting 2016
2016-04-14,Puma Biotechnology's NEfERT-T Phase II Study Published Online In JAMA Oncology
2016-03-29,Puma Biotechnology (PBYI) Stock Plunges on Delayed Marketing Application
2016-03-28,Puma Biotechnology Updates Timeline For Filing New Drug Application
2016-03-18,Puma Biotechnology Announces Publication Of Abstracts On Neratinib For The AACR Annual Meeting 2016
2016-03-02,Puma Biotechnology To Present At Cowen's Health Care Conference
2016-02-29,Puma Biotechnology Reports Fourth Quarter And Full Year 2015 Financial Results
2016-02-17,Puma Biotechnology To Participate In Fireside Chat At RBC Capital Markets Global Healthcare Conference
2016-02-16,Puma Biotechnology Announces The Conclusion And Final Results Of Eshelman's Consent Solicitation
2016-02-11,Puma Biotechnology's ExteNET Phase III Study Published Online In The Lancet Oncology
2016-02-03,Puma Biotechnology To Participate In Fireside Chat At Leerink Partners Global Healthcare Conference
2016-01-22,Interesting PBYI Put And Call Options For September 16th
2016-01-14,Puma Biotechnology Stock Sees Short Interest Make 46% Move
2016-01-09,2016 Biotech Stock Prediction: It's Going to Be a Bummer Year, Folks
2016-01-08,Puma Biotechnology Shareholders Overwhelmingly Reject Eshelman's Consent Solicitation
2016-01-04,Puma Biotechnology To Present At J.P. Morgan Healthcare Conference
2016-01-01,Feuerstein's Heroes and Zeroes of Biotech Investing in 2015
2015-12-30,Third Independent Proxy Advisory Firm Recommends That Puma Biotechnology Shareholders Reject Eshelman's Consent Solicitation By REVOKING CONSENT On Puma's BLUE Consent Revocation Card
2015-12-29,Second Leading Independent Proxy Advisory Firm Recommends That Puma Biotechnology Shareholders Reject Eshelman's Consent Solicitation By REVOKING CONSENT On Puma's BLUE Consent Revocation Card
2015-12-23,ISS Recommends That Puma Biotechnology Shareholders Reject Eshelman's Consent Solicitation By REVOKING CONSENT On Puma's BLUE Consent Revocation Card
2015-12-18,Puma Biotechnology Expands Third Cohort In Phase II Trial Of PB272 In HER2 Mutation Positive Cancer Patients
2015-12-16,Puma Biotechnology To Host Conference Call To Discuss Loperamide Prophylaxis To Reduce Neratinib-Related Diarrhea
2015-12-15,8 Stocks Spiking on Unusually High Volume
2015-12-11,Puma Biotechnology Presents 3-Year Disease Free Survival Data From Phase III Trial Of PB272 In Extended Adjuvant Breast Cancer (ExteNET Trial) At The 2015 San Antonio Breast Cancer Symposium
2015-12-10,Puma Biotechnology Presents Interim Results Of Phase II Trial Of PB272 For ERBB2 Mutant, HER2 Non-Amplified, Metastatic Breast Cancer At The 2015 San Antonio Breast Cancer Symposium
2015-12-10,Puma Biotechnology Announces Results Of Phase II Trial Of PB272 In Neoadjuvant Treatment Of HER2-Positive Locally Advanced Breast Cancer
2015-11-30,Puma Biotechnology Provides Update From Meeting With European Medicines Agency
2015-11-13,Puma Biotechnology To Present Data At The San Antonio Breast Cancer Symposium (SABCS)
2015-11-09,Puma Biotechnology Reports Third Quarter 2015 Financial Results
2015-11-03,Puma Biotechnology To Present At Credit Suisse Healthcare Conference
2015-09-26,Puma Biotechnology Announces Presentation Of Phase III Trial Of PB272 In Extended Adjuvant Breast Cancer (ExteNET Trial) In Centrally Confirmed HER2-Positive Early Stage Breast Cancer Patients
2015-09-10,Puma Biotechnology Announces Publication Of PB272 In HER2 Non-Amplified Metastatic Breast Cancer With A HER2 Mutation
2015-09-04,Battleground: Will This $5 Biotech Stock Go To $22 Or $1.50?
2015-09-03,Jim Cramer's Top Takeaways: Puma Biotechnology and H&R Block
2015-09-02,Jim Cramer's 'Mad Money' Recap: A Rally or Calm Before the Storm?
2015-08-10,Puma Biotechnology Reports Second Quarter 2015 Financial Results
2015-08-10,August 10 Premarket Briefing: 10 Things You Should Know
2015-07-31,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Puma Biotechnology, Inc. Of Pendency Of Class Action Lawsuit And A Lead Plaintiff Deadline Of August 3, 2015 - PBYI
2015-07-24,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Puma Biotechnology, Inc. Of Pendency Of Class Action Lawsuit And A Lead Plaintiff Deadline Of August 3, 2015 - PBYI
2015-07-20,Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors Of Class Action Against Puma Biotechnology, Inc. And Lead Plaintiff Deadline Of August 3, 2015
2015-07-11,'Mad Money' Lightning Round: Stay Away From Barracuda Networks
2015-07-10,Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
2015-07-03,SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Puma Biotechnology, Inc. Of Class Action Lawsuit And Upcoming Deadline - PBYI
2015-07-02,Biotech Stock Mailbag: Grading 2015 Biotech Predictions at the Halfway Point
2015-06-26,IMPORTANT INVESTOR DEADLINE: Goldberg Law PC Reminds Investors With Losses Greater Than $100,000 In Puma Biotechnology, Inc. Of The August 3, 2015 Deadline
2015-06-26,Biotech Stock Mailbag: Exelixis, Puma Bio
2015-06-23,Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Puma Biotechnology, Inc.
2015-06-22,Harwood Feffer LLP Announces Securities Class Action Lawsuit Against Puma Biotechnology, Inc. And Advises Shareholders To Contact Harwood Feffer LLP Prior To The Lead Plaintiff Deadline
2015-06-05,Biotech Stock Mailbag: More Duchenne Drama, CAR-T Trouble, ASCO '15 Rewind
2015-06-04,Puma Biotechnology To Present At Goldman Sachs Healthcare Conference
2015-06-04,Top-Performing Biotech and Drug Stocks During ASCO '15
2015-06-01,Puma Bio Breast Cancer Drug Given Rough Treatment at ASCO '15
2015-06-01,Puma Biotechnology Investors Encouraged To Contact Securities Law Firm About Investigation Into Allegations Of Corporate Wrongdoing
2015-06-01,Puma Biotechnology Announces Phase III Trial Of PB272 In Extended Adjuvant Breast Cancer (ExteNET Trial) Demonstrates Statistically Significant Improvement In Disease Free Survival
2015-06-01,Puma Biotech Hoping for a Bounce at Annual Meeting of Cancer Society
2015-06-01,ASCO '15 Report Card: Grading Biotech and Drug Stocks at Cancer Drug Confab
2015-06-01,Cancer Breakthroughs Expected at Annual Meeting of Cancer Society
2015-06-01,Oncothyreon Breast Cancer Drug Exits ASCO '15 With Good Buzz
2015-05-29,Fly Watch: Several Names That May Move Following ASCO Meeting
2015-05-28,Puma Bio Restricting Access to Breast Cancer Event at ASCO Chicago
2015-05-27,Puma Biotechnology To Present At Jefferies 2015 Healthcare Conference
2015-05-22,Biotech Stock Mailbag: ASCO Preview, CAR-T stocks, MannKind, Hate Mail!
2015-05-15,6 Stocks Spiking on Big Volume
2015-05-14,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Puma Biotechnology, Inc.
2015-05-14,Walmart Stores Is Working on a Rival to Amazon's Prime Service
2015-05-13,Puma Biotechnology Announces Publication Of Abstracts For The 2015 American Society Of Clinical Oncology (ASCO) Annual Meeting
2015-05-13,Jumpstart ASCO '15 With This Quick List of Hot Research Abstracts
2015-05-12,Puma Biotechnology To Participate In Fireside Chat At UBS Global Healthcare Conference
2015-05-11,Puma Biotechnology Reports First Quarter 2015 Financial Results
2015-05-06,Puma Biotechnology To Present At Bank Of America Merrill Lynch Health Care Conference
2015-04-30,Puma Biotechnology To Present At Deutsche Bank Health Care Conference
2015-04-27,Puma Biotechnology Larger Than S&P 500 Component Mallinckrodt
2015-04-14,Puma Biotechnology Expands Cohort In Phase II Trial Of PB272 In HER2 Mutation Positive Cancer Patients
2015-03-10,Puma Biotechnology Initiates Phase II Trial Of PB272 In Early Stage HER2-Positive Breast Cancer
2015-03-06,Biotech Stock Mailbag: Next Biotech Takeout Targets, NewLink Genetics
2015-03-05,Market News: Mallinckrodt, Kroger, Puma Biotechnology
2015-03-02,Puma Biotechnology Reports Fourth Quarter And Full Year 2014 Financial Results
2015-02-24,Puma Biotechnology To Present At Cowen Health Care Conference
2015-02-18,Puma Biotechnology To Participate In Fireside Chat At RBC Capital Markets' Global Healthcare Conference
2015-02-10,Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Puma Biotechnology, Inc.
2015-02-09,INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Puma Biotechnology, Inc. (PBYI) To Contact The Firm
2015-02-05,Puma Biotechnology To Present At Leerink Global Healthcare Conference
2015-01-27,Puma Biotechnology Closes $218 Million Public Offering Of Common Stock
2015-01-22,Puma Biotechnology Announces Underwriters' Full Exercise Of Option To Purchase Additional Shares
2015-01-22,4 Stocks Spiking on Unusual Volume: Puma Biotech, Nexstar and More
2015-01-21,Puma Biotechnology Prices Public Offering Of Common Stock
2015-01-20,Puma Biotechnology Announces Proposed Public Offering
2015-01-08,The Best And Worst Analyst Recommendations Of 2014
2015-01-06,Fifteen Fabulously Intelligent Biotech Stock Predictions for 2015
2015-01-05,Puma Biotechnology To Present At J.P. Morgan Healthcare Conference
2014-12-12,Puma Biotechnology Announces Positive Interim PB272 (Neratinib) Phase II Data At 2014 CTRC-AACR San Antonio Breast Cancer Symposium
2014-12-10,SHAREHOLDER ALERT: The Law Firm Of Levi & Korsinsky, LLP Launches An Investigation Into Possible Violations Of Federal Securities Laws By The Board Of Directors Of Puma Biotechnology, Inc.
2014-12-04,Lifshitz & Miller Law Firm Announces Investigation Of Avanir Pharmaceuticals, Inc., Carbonite, Inc., Casey's General Stores, Inc., Nymox Pharmaceutical Corporation, Puma Biotechnology Inc., RealD Inc., And Spansion, Inc.
2014-12-03,Stocks Close Higher, Helped by Continued Strength in Economy
2014-12-03,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Puma Biotechnology, Inc.
2014-12-03,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Puma Biotechnology, Inc. - PBYI
2014-12-03,Stocks Trade Higher as Services Sector Grows More Than Expected
2014-12-02,Puma Forced to Delay Breast Cancer FDA Submission Due to New Safety Data Requirement
2014-12-02,Puma Biotechnology Updates Timeline For Filing New Drug Application
2014-11-25,One Solution to the Growth vs. Value Debate: Combine Them
2014-11-21,Biotech Stock Mailbag: Northwest Bio, Celldex, Puma, MannKind
2014-11-13,Puma Biotechnology Announces Positive Top Line Results From PB272 Phase II Trial In HER2 Positive Metastatic Breast Cancer (NEfERTT Trial)
2014-11-12,Puma Biotechnology To Present At Stifel 2014 Healthcare Conference
2014-11-10,Puma Biotechnology Reports Third Quarter 2014 Financial Results
